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Lysosomal glycosylasparaginase is encoded as a 36.5 kDa polypeptide that is post-translationally processed to subunits of 19.5 kDa (heavy) and 
15 kDa (light). Recombinant glycosylasparagmase has been expressed in Spodoprerafiugiperdu insect cells enabling the precursor and processed 
forms to be isolated and their catalytic potential determined. Only the subunit conformation was functional indicating glycosylasparaginase is 
encoded as an inactive zymogen. The newly created ammo terminal residue of the light subumt following maturation, Thr-206. is believed to be 
involved in the catalytic mechanism [1992. J. Biol. Chem. 267,6855-68581. Here we have constructed two ammo acid substitution mutants replacing 
Thr-206 with Ala-206 or Ser-206 and demonstrate that both destroy enzyme activity. 
Glycosylasparagmase; Post-translational activation: Active-site mutagenesis 
1. INTRODUCTION 
Glycosylasparaginase (1-aspartamido-p-N-acetylglu- 
cosamine amidohydrolase, EC 3.5.1.26) is a lysosomal 
hydrolase that cleaves the P-N-aspartylglucosylamine 
bond of asparagine-linked glycoproteins [l]. This ami- 
dase has been biochemically characterized from various 
species and is composed of two non-identical subunits 
of approximately 25 kDa (heavy) and 19 kDa (light) 
that are held together by strong non-covalent forces 
[2,3]. Molecular cloning of the human glycosylasparag- 
inase cDNA [4] and gene [5] sequences revealed the 
heavy and light subunits are derived from a common 
precursor polypeptide. Interestingly, this post-transla- 
tional processing event appears to constitute an activa- 
tion step. Our laboratory originally proposed glyco- 
sylasparaginase might be encoded as an inactive zymo- 
gen based on expression studies of a point mutation 
(G488 + C) discovered in the human glycosylasparagi- 
nase gene pool that is responsible for the high incidence 
of the lysosomal storage disorder aspartylglucosamin- 
uria (AGU) in Finland [68]. This mutation results in 
a single amino acid substitution (Cys-163 + Ser) in the 
glycosylasparaginase heavy subunit that destroys cata- 
lytic activity and prevents post-translational processing 
of the precursor to the heavy-light subunit organization 
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[8]. The mutant Finnish AGU polypeptide is addition- 
ally not transported to the lysosome, but instead ap- 
pears trapped in the ER or other early compartment [9]. 
In a more recent study we characterized a point muta- 
tion from a British family with two AGU afthcted sib- 
lings that results in an Ala-101 + Val substitution in the 
glycosylasparaginase heavy subunit [ 10,111. Expression 
studies revealed this amino acid substitution is pheno- 
typically identical to the Finnish mutation in destroying 
catalytic activity. subunit processing, and lysosomal 
transport [l 11. 
We first attempted to experimentally demonstrate a 
correlation between glycosylasparaginase subunit mat- 
uration and enzyme activity by testing the catalytic po- 
tential of the single-chain precursor generated from an 
in vitro expression system [8]. The protocol that was 
followed had been optimized to achieve native protein 
folding and was shown by Sonderfeld-Fresko and Proia 
to produce a functional /?-N-acetyl-hexosaminidase en- 
zyme [ 121. Although the glycosylasparaginase precursor 
was unable to cleave the GlcNAc-Asn substrate and 
likely inactive. it was difficult to conclude that the trans- 
lated product had indeed attained its native conforma- 
tion. Without such assurances, the negative result could 
have been due to improper folding as opposed to a 
protein lacking catalytic activity. In this study we se- 
lected the Spodoptera frugiperda insect cell-baculovirus 
expression system as an alternative for producing the 
single-chain precursor [ 131. 
The importance of the post-translational cleavage 
event that generates the heavy and light subunits of 
glycosylasparaginase becomes more intriguing in light 
of a study by Kaartinen et al. [16]. These researchers 
showed that the hydroxyl group of Thr-206, which OC- 
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cupies the amino terminal position of the newly formed 
light subunit, forms an a-ketone ether linkage with the 
reacting group of the asparagine analog diazo-4-oxo-L- 
norvaline (DONV). This compound has been shown to 
be a potent irreversible inhibitor of glycosylasparagi- 
nase and other amidohydrolases [ 17,181. If Thr-206 is 
indeed involved in the catalytic mechanism of glyco- 
sylasparaginase as proposed by Kaartinen et al. [ 161, its 
shift from an endo-position in the precursor polypeptide 
to the amino terminus of the light subunit following 
proteolysis might have important implications for the 
catalytic mechanism. To address the role of Thr-206 at 
the glycosylasparaginase active center we have con- 
structed two mutant cDNAs. each of which carries a 
different amino acid substitution at Thr-206, for expres- 
sion in COS-1 cells. 
2. MATERIALS AND METHODS 
2.1. E.uprrssion oj‘ gl~cos~~lusparuginasr from u recombinunt hucu- 
lovirus 
A baculovirus expression vector, pVT-Bat, engineered to enhance 
secretion of heterologous proteins was kindly provtded by Dr. Thterry 
Vernet (National Research Council of Canada. Montreal, Quebec) 
and has been described [19] The critical feature of pVT-Bat is the 
presence of sequence which encodes the signal peptrde from honeybee 
melittm, a secreted protein. followed by a multiple clonmg site (MCS). 
Insertion of a transgene into the MCS allows for the production of a 
fusion protein containing the secretton-targeted honeybee mehttm sig- 
nal peptide. Here we introduced a human placenta glycosylasparagi- 
nase cDNA lacking Its signal pepttde (GSA”““) mto the MCS of 
pVT-Bat. The 5’ end of GSA-‘s’” was created by the polymerase cham 
reaction with a sense-strand oligonucleotide, 5’ CT CTG CCC CTG 
GTC GTC A 3’, that aligned to bp posmons 77-94 of the human 
placenta glycosylasparaginase cDNA [4]. The anttsense-strand primer, 
3’ AGAAATGACAGTTGTAGACA 5’. was according to bp posi- 
trons 1.046-l ,065 of the human placenta glycosylasparagmase cDNA 
3’-untranslated region [4]. PCR reaction condmons were as described 
[8]. The GSAJSlp PCR product was purified by agarose gel elution and 
cloned into a blunt-ended BarnHI site located within the MCS of 
pVT-Bat to create the plasmid pBac[mel-GSA]. This clonmg strategy 
resulted in an amino acid deletion and a substitution at the amino 
termmus of the human glycosylasparagmase heavy subumt. There- 
fore, the predicted amino terminus followmg removal of the honeybee 
melittm signal peptide would read H,N-DPLPLVVNT..., compared 
to H,N-SSPLPLVVNT... after removal of the glycosylasparagmase 
signal peptide The entire sequence of the modified human mel-GSA 
cDNA as constructed in pBac[mel-GSA] was verified by DNA se- 
quencing. 
Recombmant baculovirus containmg the mel-GSA fuston protem 
cDNA, Ac[mel-GSA]. were produced by co-transfectton of Spodop- 
tera jkgcperdu Sf9 cells wtth pBac[mel-GSA] and linear weld-type 
virus AcMNPV (Clonetech) [20] Preparative expression of recombt- 
nant mel-GSA was performed m 100 ml spinner cultures of Sf9 cells 
infected with Ac[mel-GSA] [20]. Culture media and cells were har- 
vested at 72 hours post-infectton (hpi). A small volume of the culture 
was permitted to grow for an additional 48 h to establish a 120 hpt 
time point. Cells collected at 72 hpi were pelleted, washed, and an 
extract prepared by sonicatton. Cell debris was removed by centrifuga- 
tion and the clarified supernatant applied to a 2.5 x 100 cm Sephacryl 
S-200 column at a flow rate of 0.25 ml/min Media and cell extract 
samples were analyzed by tmmunoblotting, assayed for glycosylaspar- 




Two glycosylasparagmase cDNAs, GSA4’“~‘“h and GSAs”-‘oh, repre- 
sentmg two different ammo acid substttutions at Thr-206 were con- 
structed by oligonucleottde-directed mutagenesis mediated by the 
polymerase chain reaction. For each mutant a sense-strand ohgonu- 
cleotide was synthesized that aligned to bp posmons 6055622 of the 
human placenta glycosylasparagmase cDNA [4]. Wtthm this 18 nu- 
cleotide stretch was the codon for Thr-206 and a unique BspHI 
sue directly 5’ to the mutagenests target sate The ohgo- 
nucleottdes contained a single base change at the Arst position of the 
ACTcodon encoding Thr-206 resultmg m an Ala-206 substttutton. 5’ 
ET GGT CAT GAC G_CT ATT G 3’. or a Ser-206 substttutton. 
5’ GT GGT CAT GAC TCr ATT G 3’ Each sense-strand primer 
used a common antisense-strand oligonucleotide. 3’ AGAAATGAC- 
AGTTGTAGACA 5’. which aligned to bp positions 1.046. 1,065 of 
the human placenta glycosylasparagmase cDNA 3’-untranslated re- 
gion [4]. PCR reactton conditions were as described [8]. Amphficatton 
products were purified by agarose gel elutton, dtgested with @HI, 
and ligated with a BspHl fragment encoding the glycosylasparagmase 
heavy subunit The resulting full-length mutant glycosylasparaginase 
cDNA containmg thetr respective ammo acid subsmutton were vert- 
fied by DNA sequencing. 
GSA”“.‘“” and GSASe’-‘nh were independently subcloned mto the 
expression vector pSVL (Pharmacia LKB) Transfectton mto COS-1 
cells was by the DEAE-dextran method using 5 ,&lOO mm culture 
dish of either recombinant or native pSVL [S]. Cells were harvested 
48 h post-transfectton and analyzed for the presence of recombinant 
protem and enzyme activity [8]. 
3. RESULTS AND DISCUSSION 
3.1. Expression ofprecursor andprocessed human glyco- 
sJ?lasparuginase in insect Sf9 cells 
Spinner cultures of Sfp cells were infected with either 
wild-type or recombinant Ac[mel-GSA] baculovirus 
and samples of the media collected at 24 h intervals. 
Immunoblot analysis demonstrated Sf9 cells harboring 
recombinant Ac[mel-GSA] baculovirus secreted two 
cross-reacting peptides, 41 and 26 kDa. at the sampling 
time points 24. 48, and 72 hpi, with a third peptide of 
23 kDa appearing at 72 hpi (Fig. I), These three bands 
represent the precursor glycosylasparaginase protein 
(41 kDa) and two heavy subunit variants (26 kDa and 
23 kDa). By 120 hpi only the 23 kDa heavy subunit was 
evident. Enzyme assays revealed recombinant glyco- 
sylasparaginase secreted from Actmel-GSA] bacu- 
lovirus infected St9 cells was catalytically active (Fig. 1). 
The quantity of enzyme activity secreted into the media 
increased from 24 to 120 hpi in apparent agreement 
with the increase in immunoblot band intensities over 
the same period. There was no detectable GlcNAc-Asn 
cleaving activity in the media collected from Sf9 cells 
infected with wild-type baculovirus. At 72 hpi when the 
media was harvested the total production of secreted 
glycosylasparaginase enzyme was 430 milliunits or 172 
,ug protein (protein value based on the specific activity 
of purified glycosylasparaginase being 2.5 units/mg) 
from a 100 ml spinner culture. 
A sample of the media was treated with N-glycanase 
revealing a deglycosylated 40 kDa precursor and proc- 
essed heavy subunits of 25 kDa and 22 kDa (Fig. 2). The 
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Fig. 1. Time-course analysis of secreted and intracellular human glyco- 
sylasparaginase expressed from a recombinant baculovirus. St9 cells 
were infected with Ac[mel-GSA] (lanes labeled GSA) or wild-type 
(lanes labeled &XC) baculovirus and media samples collected at 24 h 
intervals. An extract of the infected cells was prepared at 72 hpi. 
Samples were resolved on a 15% polyacrylamtde gel, electroblotted 
onto a poly(vinyhdene dtfluoride) (PVDF) (Immobtlon; Millipore) 
membrane, and incubated with antibodtes agamst the heavy subunit 
of glycosylasparagmase. The approximate molecular mass of the sin- 
gle- chain precursor and two heavy subunit tsoforms are indicated 
The glycosylasparaginase acttvity detected in medta and cell extract 
samples is given below each sample. One unit of activity was defined 
as the quantity of enzyme that released one pmole of N-acetylglu- 
cosaminelmin at 37°C. 
two heavy subunits are therefore proteolytic isoforms 
that arise during maturation of the single-chain glyco- 
sylasparaginase precursor. The first clippage likely oc- 
curs between residues Asp-205-Thr-206 resulting in the 
light subunit and the 26 kDa pre-form of the heavy 
subunit. This is followed by hydrolysis of a second pep- 
tide bond in the heavy subunit that generates the fully 
processed 23 kDa peptide. The disappearance of both 
the 26 kDa heavy subunit isoform and the 41 kDa sin- 
gle-chain precursor from the media by 120 hpi suggests 
the involvement of in vitro processing by cellular factors 
that were released into the media during baculovirus 
infection. Vernet et al. [21] observed a similar conver- 
sion of a recombinant papain zymogen secreted from 
St9 cells to a smaller molecular mass active peptide. 
Glycosylasparaginase heavy subunit processing ap- 
pears to have little significance in terms of catalytic 
potential since media samples with only the 26 kDa 
isoform (24 hpi and 48 hpi) or the fully processed 23 
kDa peptide (120 hpi) both displayed activity (Fig. 1). 
Antibodies specific for the light subunit of glycosylas- 
paraginase revealed the secreted protein from Ac[mel- 
GSA] infected cells contains two light subunit variants 
of 17 kDa and 18 kDa (Fig. 2). Unlike the two heavy 
subunits, the light subunit isoforms are due to differen- 
tial glycosylation since the two are converted to a single 
15 kDa band after removal of oligosaccharides. The 
processing of recombinant glycosylasparaginase ex- 
pressed from insect cells closely mirrors the post-trans- 
lational modifications that occur in mammalian cells. 
We have shown previously that COS-1 cells transiently 
transfected with a human placenta glycosylasparagi- 
nase cDNA express a 43 kDa precursor polypeptide 
that is post-translationally processed resulting in two 
heavy subunits (27 kDa and 24 kDa) and two light 
subunits (17 kDa and 18 kDa) [8]. 
Although the honeybee melittin signal peptide was 
capable of directing catalytically active glycosylaspar- 
aginase outside the cell, an extract of Ac[mel-GSA] 
infected cells prepared 72 hpi revealed most of the re- 
combinant protein that was expressed remained intra- 
cellular in the form of single-chain precursors 40, 41, 
and 42 kDa (Fig. 1). The 26 and 23 kDa processed 
heavy subunits and several minor proteolytic fragments 
were also evident in the cell extract but at substantially 
lower levels. None of the glycosylasparaginase peptides 
detected with the heavy subunit-specific antibodies were 
expressed by cells infected with wild-type baculovirus 
(Fig. 1). The intracellular glycosylasparaginase activity 
was determined and found to be 8-fold greater than St9 
cells infected with wild-type virus (Fig. 1). This 
amounted to 140 milliunits or 56 ,ug recombinant pro- 
tein from the 100 ml spinner culture cell pellet. There- 
fore, while the concentration of immunoreactive protein 
appeared greatest intracellularly, there was three times 
more activity in the media. The protein extract from 
Ac[mel-GSA] infected cells was resolved on a gel filtra- 
tion column in an attempt to separate the glycosylaspar- 
aginase single-chain precursor from the mature subunit 
conformation. An immunoblot of the column fractions 










Fig. 2. N-Glycase treatment of human glycosylasparaginase expressed 
m St’9 insect cells. An extract of Ac[mel-GSA] Infected cells was pre- 
pared 72 hpi and resolved on a Sephacryl S-200 gel filtration column. 
Fractions devotd of the processed subunits were pooled and treated 
with N-glycanase to remove asparagme-linked oligosacchartdes. A 
sample of the medta harvested at 72 hpi was also incubated with 
N-glycanase. Extract and media samples before (labeled -) and after 
(labeled +) N-glycanase treatment were electrophoresed on a 15% 
SDS-polyacrylamtde gel, blotted onto a PVDF membrane, and incu- 
bated wtth glycosylasparaginase heavy or light subunit-specific antt- 
bodies as Indicated. The approximate molecular mass of the precursor 
and processed peptides before deglycosylation are given. 
273 
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Heavy Light 
Glycosylasparaginase Acnvity (Bunits) 
Fig. 3. Catalytic activity of precursor and processed glycosylasparag- 
inase expressed in insect Sf9 cells and mammalian COS-1 cells. Blots 
were incubated with antibodies against the heavy or light subumts of 
glycosylasparaginase as Indicated. Each sample’s correspondmg gly- 
cosylasparagmase activity is given. Lanes labeled COS-I show recom- 
binant glycosylasparagmase expressed in COS-1 cells transiently 
transfected with a pSVL vector containing a human placenta glyco- 
sylasparaginase cDNA [8]. A sample of the single-chain precursor 
from COS-1 cells without the processed subumts IS also shown (lane 
labeled CO&I/P) This protein was generated from a pSVL vector 
containing a glycosylasparagmase cDNA sequence that encodes the 
Finnish AGU G488 + C point mutation [8] Lanes labeled Sp[S/ 
contain recombinant glycosylasparaginase secreted from Ac[mel- 
GSA] infected Sf9 cells, while lanes labeled SfO[S]A show an ahquot 
of the same material heated at 65°C for 15 mm. Samples of mtracellu- 
lar recombinant glycosylasparagmase from Ac[mel-GSA] infected St9 
cells before (lane labeled S’[C/) and after (lane labeled S’(C/A) 
heat treatment at 65°C are also shown The intracellular precursor 
from Ac[mel-GSA] infected Sf9 cells followmg gel filtration chroma- 
tography appears in the lane indicated S’IP The approximate molec- 
ular masses of the glycosylasparaginase peptldes expressed in St9 cells 
are shown. 
precursor eluted with a slightly earlier retention time 
compared to the processed form, resulting in several 
early fractions that were free of the glycosylasparagi- 
nase subunits (data not shown). These fractions were 
pooled, subject to N-glycanase digestion, and visualized 
with heavy subunit-specific antibodies. Removal of as- 
paragine-linked oligosaccharides resulted in the same 
40 kDa band that was detected in the deglycosylated 
media sample (Fig. 2). The three intracellular single- 
chain forms that were present before digestion therefore 
represent the precursor polypeptide lacking asparagine- 
linked sugars (40 kDa) and two carbohydrate variants 
(41 kDa and 42 kDa). 
Having obtained a preparation of the glycosylaspar- 
aginase precursor absent of the processed subunits. an 
enzyme assay was performed to determine its catalytic 
potential. No detectable release of free glucosamine 
from the GlcNAc-Asn substrate was observed (Fig. 3). 
This indicated that the recombinant activity detected in 
the extract and media from cells infected with the 
Ac[mel-GSA] baculovirus was due to the processed sub- 
unit conformation. However, to avoid any ambiguity 
we sought to remove the single chain precursor from the 
media and cell extracts that were harvested at 72 hpi. 
This was accomplished by taking advantage of the heat 
stability conferred by the native glycosylasparaginase 
conformation [3,22]. After heating the sample and re- 
moving any denatured material by centrifugation, im- 
munoblotting revealed the precursor had been precipi- 
tated while the majority of the processed heavy and light 
subunits remained soluble (Fig. 3). The heat treated 
sample also retained 65% of its enzyme activity. The 
selective removal of the precursor polypeptide from the 
processed active enzyme was further shown with a sam- 
ple from the intracellular extract (Fig. 3). The contrast- 
ing data showing the precursor is catalytically inactive 
while the processed heavy-light subunit organization is 
functional provide convincing evidence that glycosylas- 
paraginase is a zymogen (Fig. 3). Samples of the precur- 
sor and processed formes of glycosylasparaginase ex- 
pressed in COS-I cells have been included in Fig. 3 
along with those from Sf9 cells to demonstrate their 
similarity in processing and associated activities. 
3.2, Mutagenesis of Th-206 destrojss gl~~cosylusparugi- 
Two different glycosylasparaginase cDNAs were 
constructed by in vitro mutagenesis to determine the 
importance of Thr-206 for catalysis. The first encoded 
a Thr-206 + Ala substitution at amino acid position 
206 ( GSAAld-“” ) and the second a Thr-206 -+ Ser substi- 
tution ( GSASer-“’ ). Expression in COS-1 cells revealed 
neither of the two substitution mutants produced an 
increase in GlcNAc-Asn cleaving activity above mock 
transfected cells (Fig. 4). This result was in contrast to 
cells transfected with the normal human placenta glyco- 
(munits/mg) 
Fig. 4. Expression of glycosylasparaginase active site mutants in COS- 
1 cells. Lysates from cells transfected with the human placenta cDNA 
HPAsn.6 [4]. GSA4’“-“‘h. GSASe’-“‘h, or mock-transfected with the na- 
tne pSVL expression vector were resolved on a 15% SDS-poly- 
acrylamlde gel and electrophoretically transferred to a PVDF mem- 
brane. The blot was incubated aith heavy subunit-specific antibodies. 
Ahquots of the same lysates used for lmmunoblot analysis were alao 
assayed for glycosylasparaginase activity. The specific activity of each 
lysate is given in milhunits/mg (nanomoles N-acetylglucosamme re- 
leased/mm/mg protem at 37°C). 
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sylasparaginase cDNA HPAsn.6 where a 13-fold in- 
crease in the release of free glucosamine was observed. 
The presence of recombinant glycosylasparaginase in 
the transfected COS-1 cell lysates was demonstrated by 
immunoblot analysis with antibodies specific for the 
heavy subunit. The fully processed 24 kDa heavy sub- 
unit was found to be the predominant immunoreactive 
peptide in COS-1 cells expressing the human placenta 
cDNA HPAsn.6, with minor quantities of the 27 kDa 
heavy subunit pre-form and 43 kDa precursor polypep- 
tide also present (Fig. 4). None of the glycosylasparag- 
inase specific bands were detected in mock-transfected 
cells (Fig. 4). COS-1 cells transfected with either of the 
glycosylasparaginase substitution mutants contained 
the 24 kDa heavy subunit revealing the lack of enzyme 
activity was not due to the absence of recombinant pro- 
tein (Fig. 4). Interestingly, a significant quantity of the 
43 kDa glycosylasparaginase precursor accumulated in 
cells transfected with the GSAA’“-“06 cDNA. This inhib- 
itory effect on subunit processing likely contributes to 
the absence of catalytic function. 
According to the glycosylasparaginase reaction 
mechanism as proposed by Kaartinen et al. [ 161, the first 
of three symmetrical steps involves the formation of a 
/I-aspartyl acyl-enzyme intermediate mediated through 
the hydroxyl group of Thr-206. Therefore, it would 
seem reasonable to suggest that the inactive state of the 
Ala-206 mutant is due in part to the lack of a nucleo- 
philic hydroxyl moiety. This same reasoning cannot be 
applied to the Ser-206 mutant. One possible explanation 
for the absence of glycosylasparaginase activity is that 
the Ser-206 substitution interferes with correct subunit 
processing. In this instance the heavy and light subunits 
are formed (Fig. 4), however, post-translational proc- 
essing fails to place Ser-206 at the newly formed amino 
terminus of the light subunit. Proteolytic cleavage at a 
nearby cryptic site is one model where subunit process- 
ing could occur without yielding an amino terminal 
Ser-206. Although the inability to exchange Ser-206 for 
Thr-206 without compromising glycosylasparaginase 
catalytically activity is difficult to rationalize in the ab- 
sence of refined structural data, it is of interest that there 
appears to be a tight evolutionary conservation for an 
active site threonine residue among mammalian [23], 
bacterial [24], yeast [25] and plant [26] amidohydrolases. 
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Note added in proof 
Recently Ikonen et al. [27] using site-specific mutagenesis have also shown that conversion of the single chain form of glycosylasparaginase into 
its heavy and light chains is an activation step that occurs prior to the lysosomes. 
275 
